Stamford, CT -- (SBWIRE) -- 12/30/2013 -- Jet Life Penny Stocks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: NewLead Holdings Ltd(NASDAQ:NEWL), Stereotaxis Inc (NASDAQ:STXS), Oxygen Biotherapeutics, Inc.(NASDAQ:OXBT), Cereplast Inc(OTCMKTS:CERP)
NewLead Holdings Ltd(NASDAQ:NEWL) was a volume gainer of 3.48 million shares and the average volume of the stock remained 496,162.00 shares. The stock opened the session at $2.16 and finished at the end of the day at $1.80 and the stock plunged -8.63%.The market capitalization of the stock remained 15.88 million. NewLead Holdings Ltd., a shipping and commodity company, is engaged in the transportation of refined products and dry bulk goods worldwide. The company transports various products, including gasoline, jet fuel, iron ore, coal, and grains.
Has NEWL Found The Bottom And Ready To Gain Momentum? Find Out Here
In the preceding trading session, Stereotaxis Inc (NASDAQ:STXS) exchanged 764,543 shares and the average volume remained 671,309.00 shares. The stock closed the session at $3.77 with the drop of -7.14%. Stereotaxis, Inc. designs, manufactures, and markets cardiology instrument control system in the United States and internationally. Its products include Niobe ES robotic magnetic navigation system that enables physicians to navigate catheters, guidewires, and other delivery devices through the blood vessels and heart chambers to treatment sites; and Vdrive Robotic Navigation System, which provides navigation and stability for the diagnostic and ablation devices that assist in the delivery of ablations.
Why Should Investors Buy STXS After the Recent Fall? Just Go Here and Find Out
Oxygen Biotherapeutics, Inc.(NASDAQ:OXBT) decreased -6.02% and its closing price was $4.84. The volume of the stock was 734,417 shares and the average volume remained 1.59 million shares. The market capitalization of the stock remained 51.42 million. The beta of the stock remained 0.50. Oxygen Biotherapeutics, Inc., a development stage company, engages in developing biotechnology products that deliver oxygen to target tissues in the body primarily in the United States. It develops Oxycyte, a systemic perfluorocarbon based oil in water emulsion oxygen carrier for use in situations of acute ischemia; and is in Phase II-b clinical trial for the treatment of traumatic brain injury.
Will OXBT Get Buyers Even After The Recent Rally? Find Out Here
Cereplast Inc(OTCMKTS:CERP) exchanged 20.30 million shares in the previous trading session, and its average trading remained 42.06 million shares. CERP dropped -5.56% and it closed the trading at $0.0051. The market capitalization of the stock remained 3.67 million. Cereplast, Inc. develops and commercializes bio-based resins. It provides Cereplast Compostables resins, which are compostable, bio-based, and ecologically sound substitutes for petroleum-based plastics targeting compostable bags, single-use food service products, and packaging applications.
Has CERP Found The Bottom and Ready To Move Up? Find Out Here
Jet Life Penny Stocks is always searching the market every day for massive penny stock runs before they happen so you don't have to. Our Penny Stock Newsletter also offers free Highly-Professional Grade stock charts and video charts from one of the most experienced and well-respected chartists in the penny stock industry.
Jet Life Penny Stocks is not a registered securities advisor. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides information on highlighted stocks via press releases, newsletters and company website, but this should not be construed as a recommendation to buy or sell. Please visit the company website for a more complete list of risks and disclosures.
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)